MedDataX Logo

Substance Use Screening Among Drug User

NCT ID: NCT02951858

Last Updated: 2016-11-01

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

218 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to improve the ability of primary medical staffs in screening and intervention for alcohol, benzodiazepines, and other illicit drug use.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

In order to reduce the social and personal harm caused by drugs, it is urgent to strengthen the ability of the primary health institutions in screening and intervention the addictive substances use. Firstly, the investigators will invite 10 primary medical staffs and 10 experts in addition to revise the manual of Alcohol, Smoking, and Substance Use Involvement Screening Test (ASSIST) and Brief Intervention (BI). Then, the investigators will recruit 100 medical staffs to participate the training of ASSIST and BI. Secondly, the researcher will investigate the effects of BI technology in reducing the use of addictive substances, improve the addiction related knowledge of patients through randomized controlled study. Finally, the investigators will collect the research information, revise the manual, and promote the training.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Substance Use

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Alcohol,Smoking,and Substance Use Involvement Screening Test Brief Intervention Substance Use Primary Medical and Health Care Institution

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention Group

The medical staffs who received the training will use the manual of brief intervention to deliver it and other materials about the harm of substance use.

Group Type EXPERIMENTAL

Intervention Group

Intervention Type BEHAVIORAL

The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.

Control Group

The participants only receive the materials about the harm of substance use.

Group Type ACTIVE_COMPARATOR

Control Group

Intervention Type BEHAVIORAL

The participants only receive the materials about the harm of substance use.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intervention Group

The medical staffs who received the training will use the manual of brief intervention to deliver BI and other materials about the harm of substance use.

Intervention Type BEHAVIORAL

Control Group

The participants only receive the materials about the harm of substance use.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. aged 18-60 years;
2. the patient to the community medical institutions;
3. ASSIST score is in 12-27, in a moderate risk;
4. voluntary to participate;
5. to agree to complete baseline interviews and follow-up studies.

Exclusion Criteria

1. unable to complete the questionnaire;
2. serious physical illness, action inconvenience.
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Shanghai Mental Health Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

DU, Jiang

Cheif Physician

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jiang Du, M.D

Role: PRINCIPAL_INVESTIGATOR

Shanghai Mental Health Center

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Jiang Du, M.D

Role: CONTACT

Phone: 18017311220

Email: [email protected]

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

JDu-003

Identifier Type: -

Identifier Source: org_study_id